邮箱：caitingmeng@zzu.edu.cn

个人简介

孟彩婷，初聘副教授，硕士生导师。2025年6月毕业于西安交通大学，获理学博士学位，同年12月加入郑州大学医学前沿交叉学院。主持国家自然科学基金青年项目1项，以第一或共同第一作者在Advanced Functional Materials、ACS Nano等期刊发表SCI论文3篇。

主要研究方向

靶向肠道纳米药物递送系统的开发及应用研究、蛋白质组学及纳米医学技术在肿瘤治疗中的应用

代表性成果：

#共同一作

1、Meng C, Qiao C, Hao Q, Shi J, Lou C, Song J, Wang L, Yang J, Ma X, Kang H, Wu H, Yu Z^*, Li S^*. Hierarchical Precision Nanoplatform for Synergistic Radio-Immunotherapy in Glioblastoma via Controllable P-Selectin Targeting. Adv. Funct. Mater. 2026, 36(17): e16391.

2、Meng C^#, Li S^#, Ma Y^#, Yu H, Song J, Zhi J, Zhu B, Shao L, Liu X, Yang L, Zhang M^*, Zhang Y^*, Li G^*. Assembling Ruthenium Complexes to Form Ruthenosome Unleashing Ferritinophagy-Mediated Tumor Suppression. ACS Nano. 2025, 19(10): 10207-10219.

3、Li S^#, Meng C^#, Hao Q, Zhou R, Dai L, Guo Y, Zhao S, Zhou X, Lou C, Xu J, Xu P, Yang J, Ding Y, Lv Y, Han S, Li S, Li J, Kang H, Xiao Z, Tan M, Ma X^*, Wu H^*. “On/off”-switchable Crosslinked PTX-nanoformulation with Improved Precise Delivery for NSCLC Brain Metastases and Restrained Adverse Reaction over Nab-PTX. Biomaterials. 2024, 307(4): 122537.

4、Li S, Meng C, Hao Q, Dai L, Shi J, Xu J, Zhou X, Zhao S, Yang J, Kang H, Hou Y, Zhang M, Ma X, Tan M, Wu H^*. A Multistage Responsive Antibody-Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor-Anchoring. Adv. Funct. Mater. 2024, 34: 2312595.

5、Hou Z, Meng C, Yang F, Deng Y, Han X, Liu H^*. Mapping Tyrosine Kinases Based on a TK Activity-Representing Peptide Library Reveals a Role for SRC in H1975 Drug Resistance. J. Proteome Res. 2022, 21(4): 1105–1113.